MucoLife Therapeutics AB
559463-2159ActiveDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Biotechnology Companymucolife.com
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2023
- Founded
Key Decision Makers
Kicki Johansson
Chief Development Officer
@mucolife.com
Jesper Magnusson
Board Member
@mucolife.com
Gunnar C. Hansson
Co-founder and Chief Scientific Officer
@mucolife.com
Jim Shaffer
Chief Business Officer
@mucolife.com
+6 more contacts in Funnelfeedr
Description
MucoLife Therapeutics is a pioneering biotechnology firm dedicated to transforming the treatment landscape for chronic lung diseases. The company specifically targets pulmonary mucus obstruction, a debilitating symptom affecting patients with conditions like Chronic Obstructive Pulmonary Disease (CO...